Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site

Cancer Letters

Volumn 107, Issue 1, 1996, Pages 53-57

  Mooberry, Susan L ^a   Taoka, Christy R ^a   Busquets, Lizette ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Antimicrotubule; Colchicine; Cryptophycin; Tubulin; Vinblastine

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CHYMOTRYPSIN; COLCHICINE; CYTOTOXIC AGENT; DIPEPTIDE; MAYTANSINE; RHIZOXIN; TRYPSIN; VINCA ALKALOID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG BINDING SITE; DRUG PROTEIN BINDING; MICROTUBULE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE;

VINCA;

EID: 0030272586     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04342-X     Document Type: Article

References (19)

1. [1] Trimurtulu, G., Ohtani, I., Patterson, G.M.L., Moore, R.E., Corbett, T.H., Valeriote, F.A. and Demchik, L. (1994) Total structures of cryptophycins, potent antitumor depsipeptides from the blue-green alga Nostoc sp. strain GSV 224, J. Am. Chem. Soc., 116, 4729-4737.
2. [2] Barrow, R.A., Hemscheidt, T., Liang, J., Paik, S., Moore, R.E. and Tius, M.A. (1995) Total synthesis of cryptophycins: revision of the structures of cryptophycins A and C, J. Am. Chem. Soc., 117, 2479-2490.
3. [3] Schwartz, R.E., Hirsch, C.F., Sesin, D.F., Flor, J.E., Chartrain, M., Fromtling, R.E., Harris, G.H., Salvatore, M.J., Liesch, J.M. and Yudin, K. (1990) Pharmaceuticals from cultured algae, J. Ind. Microbiol., 5, 113-124.
4. [4] Hirsch, C.F., Liesch, J.M., Salvatore, M.J., Schwartz, R.E. and Sesin, D.F. (1990) Antifungal Fermentation Products and Methods. US Patent 4946835.
5. [5] Smith, C.D., Mooberry, S.L., Zhang, X. and Helt, A.-M. (1994) A sensitive assay for taxol and other microtubule-stabilizing agents, Cancer Lett., 79, 213-219.
6. [6] Smith, C.D., Zhang, X., Mooberry, S.L., Patterson, G.M.L. and Moore, R.E. (1994) Cryptophycin: a new antimicrotubule agent active against drug-resistant cells, Cancer Res., 54, 3779-3784.
7. [7] Golakoti, T., Ogino, J., Heltzel, C.E., Le Husebo, T., Jensen, C.M., Larsen, L.K., Patterson, G.M.L., Moore, R.E., Mooberry, S.L., Corbett, T.H. and Valeriote, F.A. (1995) Structure determination, conformational analysis, chemical stability studies, and antitumor evaluation of the cryptophycins: isolation of 18 new analogs from Nostoc sp. strain GSV 224, J. Am. Chem. Soc., 117, 12030-12049.
8. [8] Bollag, D.M., McQueney, P.A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M., Lazarides, E. and Woods, C.M. (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action, Cancer Res., 55, 2325-2333.
9. [9] Ter Haar, E., Kowalski, R.J., Hamel, E., Lin, C.M., Longley, R.E., Gunasekera, S.P., Rosenkranz, H.S. and Day, B.W. (1996) Discodermolide: a cytotoxic marine agent that stabilizes microtubules more potently than taxol, Biochemistry, 36, 243-250.
10. [10] Sackett, D.L. (1993) Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin, Pharmacol. Ther., 59, 163-228.
11. [11] Hamel, E. (1992) Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatin 10 and 15 and halichondrin B, Pharmacol. Ther., 55, 31-51.
12. [12] Sackett, D.L. and Varma, J.K. (1993) Molecular mechanism of colchicine action: induced local unfolding of β-tubulin, Biochemistry, 32, 13560-13565.
13. [13] Sackett, D.L. (1995) Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents, Biochemistry, 34, 7010-7019.
14. [14] Stewart, K.K. (1973) A method for automated analyses of the activities of trypsin, chymotrypsin and their inhibitors, Anal. Biochem., 51, 11-18.
15. [15] Best, D., Warr, P.J. and Gull, K. (1981) Influence of the composition of commercial sodium dodecyl sulfate preparations on the separation of α-and β-tubulin during polyacrylamide gel electrophoresis, Anal. Biochem., 114, 281-284.
16. [16] Sackett, D.L. and Wolff, J. (1986) Proteolysis of tubulin and the substructure of the tubulin dimer, J. Biol. Chem., 261, 9070-90676.
17. [17] Kerksiek, K., Mejillano, M.R., Schwartz, R.E., Georg, G.I. and Himes, R.H. (1995) Interaction of cryptophycin 1 with tubulin and microtubules, FEBS Lett., 377, 59-61.
18. [18] Smith, C.D. and Zhang, X. (1996) Mechanism of action of cryptophycins, J. Biol. Chem., 271, 6189-6192.
19. [19] Bai, R., Pettit, G.R. and Hamel, E. (1990) Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites, J. Biol. Chem., 265, 17141-17149.